Martin Shkreli, a former pharmaceutical executive best known for pumping the price of a life-saving drug by 5,000%, is launching his new cryptocurrency-focused startup called Druglike.
Subscribe to our Telegram channel to get daily short digests about events that shape the crypto world
Shkreli's new venture is aimed at democratizing the costs, access, and rewards of computational drug discovery, a press release says. Shkreli, who was released from prison for lying to hedge fund investors, says his new project will "remove barriers to early-stage drug discovery, increase innovation and allow a broader group of contributors to share the rewards." He added:
"Underserved and underfunded communities, such as those focused on rare diseases or in developing markets, will also benefit from access to these tools."
Based on a "decentralized computing network" with a modernized consensus algorithm called Proof-of-Optimization, Druglike will also give validators the way to monetize their efforts for a native token called MSI.
With MSI, validators can run both solver and validator nodes "powering industrial-scale virtual screening campaigns," the press release says.
Access more than 50 of the world's financial markets directly from your EXANTE account – including NASDAQ, London Stock Exchange and Tokyo Stock Exchange